home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

China Vaccines 2012

  January 04, 2012  
IBC Asia , Grand Hyatt Shanghai China
23-26 April 2012

• Novel Vaccine Candidates for Tropical Diseases

• Research and Clinical Updates for EV71 vaccines

• Innovations & Technological Advancements

• Future Opportunities for Sustainable Return on Investment

• Market Trends & Outlook

• Vaccines Quality Control & Compliance

• Novel Development of Vaccines

• Regulatory Snapshots

• Visionary Panel Discussion

Organized by: IBC Asia (S) Pte Ltd
Invited Speakers:

Mary Haak-Frendscho, President and Chief Scientific Officer, Takeda San Francisco, USA

Joe McCracken, Global Head of Business Development and Licensing, Roche, USA

Dr Helmut Haning, Senior Vice President and Head Global Innovation Outsourcing, Bayer Healthcare Pharmaceuticals, Germany

Frank Shen, Vice President Global Data Management and Statistics, Global Pharmaceutical R&D, Abbott, USA

Ling Chen, Vice President of R&D China Operations, GlaxoSmithKline, China

Ming Wang, Executive Director and Head of Diabetes Research, Amgen, USA

Youling Wu, Chief Executive Officer, ZheJiang Teruisi, China

Dr. Li Shi, Ph.D., CEO, Shanghai Zerun Biotechnology, Wison Group, China

Dr. Aihua Zhang, Professor and Deputy Director of R&D, China National Biotech Group (CNBG), China National Pharmaceutical Group Corp.(Sinopharm), China

 Giridhar Rao, Manager of Global Regulatory Affairs and Compliance, Indian Immunologicals, India

and many more

Deadline for Abstracts: 01/03/2012

Customer Service Hotline 客户服务热线

+65 6508 2401 (Singapore)

+86 21 2326 3680 (China)


Email 电子邮件



Web 网络


E-mail: rita.parasurum@ibcasia.com.sg
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.